International Research Journal of Public and Environmental Health

Original Research Article

The study of brain natriuretic peptide level and heart rate turbulence in acute coronary syndrome


1
2

*Corresponding Author Email: wxwuchao(at)163.com

Tel.+8615301516886

Chao Wu*1

Tao Ding2

Weidong Jin1

Yimin Wang1

Lijuan Wu1

Chun Fan1

Feng Hu1


Article Number: irjpeh.16.036  |   Pages: 293-298  |   Vol.3 (12), December 2016   |   DOI: http://dx.doi.org/10.15739/irjpeh.16.036

 Received: October 28, 2016  Accepted: December 5, 2016  Published: December 9, 2016

Abstract

This study aims to investigate the effect of serum brain natriuretic peptide (BNP) level and heart rate turbulence (HRT) phenomena on changes in acute coronary syndrome (ACS) patients, and their roles in predicting the evaluation of recent cardiovascular event. According to clinical diagnosis and coronary artery angiography results, 102 patients were divided into three groups; ST-elevation myocardial infarction (STEMI), non ST-elevation myocardial infarction (NSTEMI) and unstable angina (UA). The BNP and HRT results were determined upon performance of parallel color doppler ultrasound examination. Major adverse cardiac events (MACE) during hospitalization and within 90 days after discharge were analyzed. BNP level significantly differed between ACS and control groups (P < 0.05). With ACS degree aggravating, the classification of HRT in HRT2 increased significantly. Comparisons between with and without MACE shows an increase in BNP level, HRT2 ratio and Turbulence Onset (TO) with a decrease in turbulence slope (TS). The levels of BNP in patients with ACS are good indicators of the severity of ACS. HRT phenomenon is associated with ACS type. BNP and HRT are correlated with recent adverse cardiovascular events

Keywords: acute coronary syndrome, brain natriuretic peptide, heart rate turbulence, major adverse cardiac events.

How to Cite this Article

Author(s) agree that this article remain permanently open access under the terms of the Creative Commons Attribution License 4.0 International License.


Select Language »